Evidence map›Paper›PMID 42464244›Full record

ReviewJournal of nanobiotechnology2026

Integrating silver nanomaterials in wound healing: from physicochemical properties to clinical translation.

Haishan Zhang, Kai You, Qifang Liu, Xuewen Xu, Rui Hua, Liming Wang

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haishan Zhang *Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, 110000, China.
Kai You *Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110000, China.
Qifang Liu *Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Xuewen XuDepartment of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. xuxw@sj-hospital.org.
Rui HuaDepartment of Ophthalmology, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, China. woodshua@126.com.
Liming WangDepartment of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, China. wanglm@cmu1h.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wound healing is a complex process that involves the interplay of infection, inflammation, and tissue regeneration. Nevertheless, the conventional therapies tend to treat these processes individually. Silver nanomaterials have been found to serve as platforms for surface chemistry and controlled ion-release kinetics, conferring a wide array of biological activities beyond their traditional antimicrobial applications and making them promising therapeutic platforms with broad-spectrum antimicrobial, immunomodulatory, and regenerative properties. Their versatile physicochemical properties, such as size and morphology. This review provides a critical, detailed examination of the biological processes that determine the therapeutic effects of silver nanomaterials, as well as their design principles and physicochemical properties. We discuss their multi-target antimicrobial effects against bacterial, fungal, and viral infections, as well as their role in regulating innate and adaptive immunity during wound healing, including in biofilm infections. These materials, along with soft-tissue and internal-organ repair, are discussed in both cutaneous and non-cutaneous applications, as well as in orthopedic and dental applications. Moreover, the most significant translational considerations, such as safety, dose-dependent toxicity, biodistribution, the long-term fate, and regulatory factors, are critically examined. The review highlights the importance of drawing on insights from materials science, microbiology, immunology, and regenerative medicine to demonstrate how rationally designed silver nanomaterials can address unmet clinical needs and identify opportunities for their safe and effective clinical use.

Indexed as

Metal NanoparticlesNanostructuresSilverWound HealingAnimalsAnti-Infective AgentsBiofilmsHumansAnti-Infective AgentsSilverAntimicrobial mechanismsBiofilmsImmunomodulationInflammation controlNanobiotechnologySilver nanomaterialsTissue regenerationTranslational nanomedicineWound healing

Identifiers

PMID42464244
PMCPMC13491624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.